Cell Harvesting Market | Growing at a CAGR of 8.7% | Increasing Incidence of Chronic and Infectious Diseases

PUNE, India, 2020-Sep-11 — /EPR Network/ —

According to the new market research report “Cell Harvesting Market by Type (Manual, Automated), Application (Biopharmaceutical, Stem Cell Research), End User (Biotechnology, Biopharmaceutical Companies, Research Institute), and Region (North America, Europe, APAC, Row) – Global Forecast” published by MarketsandMarkets™.

The Cell Harvesting Market is expected to grow at a CAGR of 8.7%, to reach USD 324.5 Million.

Cell harvesting is the process of harvesting cells from the culture media during upstream and downstream bio-processing. Cell harvesters are used extensively for the cell harvesting process and are compatible with a wide range of assays.

Major Market Growth Drivers:

• Rising Investments in Regenerative Medicine and Cell-Based Research
• Growth of the Biotechnology and Biopharmaceutical Industry
• Increasing Incidence of Chronic and Infectious Diseases
• Growth Opportunities in Emerging Economies

Browse 67 market data Tables and 27 Figures spread through 101 Pages and in-depth TOC | Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=209513544

The manual cell harvesters segment dominated the market.

On the basis of type, the market is segmented into manual and automated cell harvesters. In 2017, the manual cell harvesters segment accounted for the largest share of this market. The high share of the manual harvesters segment can be attributed to their ease of use and low price as compared to automated harvesters.

The biotechnology & biopharmaceutical companies segment dominated the market.

In the end user, the cell harvesting market is segmented into research institutes, biotechnology & biopharmaceutical companies, and other end users. In 2017, the biotechnology & biopharmaceutical companies segment accounted for the largest share of the cell harvesters market. The high share of this segment can be attributed to the high prevalence of chronic diseases. Biotechnology & biopharmaceutical companies conduct R&D activities to develop new products for the treatment of these diseases.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=209513544

By region, the global cell harvesting market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). While North America held the largest share of the market, Asia Pacific is expected to register the highest CAGR during the forecast period. As increasing R&D expenditure helps in the development of new treatment solutions, supportive government policies for stem cell research and increasing public-private initiatives to encourage public adoption of stem cell-based treatment in the Asia Pacific countries are driving the growth of the market in this region.

Some of the major players operating in the cell harvesting market are PerkinElmer (US), Brandel (US), TOMTEC (US), Cox Scientific (UK), Connectorate (Switzerland), Scinomix (US), ADSTEC (Japan), and Terumo BCT (a part of Terumo Corporation) (Japan).